InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Lis William, 董事. Officer active across 3 companies, notably Zai Lab Ltd. Cumulatively, 15 filings have been published. Split: 0 buy · 8 sells. Total volume traded: €1.2m. History available since 3 January 2022. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lis William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
8,506 股@ US$25.000.0080% mcap9.9% 占其流量American Depositary SharesSEC:0000905148-26-003620:0
10,831 股0American Depositary SharesSEC:0000905148-25-002215:0
15,000 股@ US$32.9832.2% 占其流量American Depositary SharesSEC:0000905148-25-000827:0
10,297 股@ US$17.313911.2% 占其流量American Depositary SharesSEC:0000905148-24-001839:0
21,253 股0American Depositary SharesSEC:0000905148-24-001748:0
7,965 股@ US$0.85089.9% 占其流量Voting Common StockSEC:0001013762-23-003901:0
18,903 股@ US$26.4531.1% 占其流量American Depositary SharesSEC:0000950170-23-031097:0
8,500 股@ US$1.4417.0% 占其流量Voting Common StockSEC:0001213900-23-029888:0
5,434 股@ US$38.3113.3% 占其流量American Depositary SharesSEC:0000899243-23-007333:0
29,500 股0Voting Common StockSEC:0001213900-22-063936:0
24,743 股@ US$2.0220.22% mcap100.0% 占其流量Voting Common StockSEC:0001213900-22-035570:0
89,972 股0Voting Common StockSEC:0001213900-22-014562:0
1,926 股@ US$53.406.0% 占其流量Ordinary SharesSEC:0001567619-22-001445:0
7,763 股0Ordinary SharesSEC:0001567619-22-000397:0
28,125 股Common StockSEC:0001209191-16-094215:0
15 条申报中的 15 条
About Lis William
Lis William is an Administrateur at Zai Lab Ltd and Jasper Therapeutics, Inc., and Chief Executive Officer at PORTOLA PHARMACEUTICALS INC. He has 14 filings in total, and across the 14 sampled filings between 2016-01-29 and 2025-06-23, sell transactions total 994065 EUR and Attribution is the modal transaction nature.
